F-18 Choline PET Does Not Detect Increased Metabolism in F-18 Fluoroethyltyrosine-Negative Low-Grade Gliomas
Authors:
- Ulrich RoelckeURUlrich Roelcke
- Matthias BruehlmeierMBMatthias Bruehlmeier
- Martin HeftiMHMartin Hefti
- Thomas HundsbergerTHThomas Hundsberger
- Egbert U. NitzscheENEgbert U. Nitzsche
- 1 January 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 37 (1) , e1-e3
Abstract
Positron emission tomography (PET) with radiolabeled amino acids provides information on biopsy target and chemotherapy response in patients with low-grade gliomas (LGG). In this article, we addressed whether PET with F-18 choline (CHO) detects increased metabolism in F-18 fluoroethyltyrosine (FET)-negative LGG patients. Six LGG patients with nongadolinium-enhancing (magnetic resonance) FET-negative LGG were imaged with CHO PET. Regions of interest were positioned over tumor and contralateral brain. Uptake of FET and CHO was quantified as count ratio of tumor to contralateral brain. The mean FET uptake ratio for FET-negative LGG was 0.95 ± 0.03 (mean ± standard deviation). Five tumors did not show increased uptake ratios for CHO (0.96 ± 0.12). Slightly increased CHO uptake was found in 1 patient (1.24), which, however, was not associated with tumor visualization. Amino acid and choline uptake appear to behave similar in nongadolinium-enhancing LGG. For clinical purposes, CHO PET is not superior to FET PET.Keywords
This publication has 11 references indexed in Scilit:
- Comparative Evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for Metabolic Imaging of Low Grade GliomasClinical Nuclear Medicine, 2009
- Early metabolic responses in temozolomide treated low-grade glioma patientsJournal of Neuro-Oncology, 2009
- Metabolic Assessment of Gliomas Using11C-Methionine, [18F] Fluorodeoxyglucose, and11C-Choline Positron-Emission TomographyAmerican Journal of Neuroradiology, 2008
- Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomasJournal of Neuro-Oncology, 2008
- FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour gradingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Metabolic and molecular imaging in neuro-oncologyThe Lancet Neurology, 2007
- Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 Gliomas and Correlation with 131I-SIP(L19), a Marker of AngiogenesisJournal of Nuclear Medicine, 2007
- Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L-tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the ratEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging—guided stereotactic biopsy sampling of gliomasJournal of Neurosurgery, 2003
- Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRSJournal of Neuro-Oncology, 2003